 EMERYVILLE, Calif., Jan. 18, 2023 GLOBE NEWSWIRE -- Gritstone bio, Inc. Nasdaq: GRTS, a clinical-stage biotechnology company working to develop the worlds most potent vaccines, today announced that management will participate in the following investor conferences. 